Sotto Pelle Therapy
SottoPelle Therapy is a Scottsdale-based, privately held BHRT company that trains and certifies a global network of 1,200+ medical providers in its proprietary subcutaneous pellet therapy, supported by the Dosaggio™ dosing platform, while operating flagship clinics and consumer wellness brands.
- Company typePrivate
- Founded2004
- HeadquartersScottsdale, United States
- Headcount51–100
- GTM typeB2B and B2C
- OfferingServices
What Sotto Pelle Therapy does
SottoPelle Therapy is a privately held US healthcare company specializing in bioidentical hormone replacement therapy (BHRT) delivered through subcutaneous hormone pellets. Founded in 2004 by Dr. Gino Tutera based on a pellet-therapy method he developed in 1992, the company is headquartered in Scottsdale, Arizona, and is now led by CEO CarolAnn Tutera. Its core technology is the proprietary SottoPelle® Pellet Method, which inserts plant-derived bioidentical hormone pellets under the skin to release consistent, 24/7 doses over four to six months, paired with the multi-patented Dosaggio™ dosing platform that calculates individualized hormone dosages for each patient. The company states it has treated more than 250,000 patients over 30 years and operates a network of 1,200+ certified providers across the US, Puerto Rico, Spain, Brazil, and Mexico.
SottoPelle operates a B2B provider-training-and-certification model as its primary go-to-market, training OB/GYNs, family physicians, PAs, and nurse practitioners to deliver the SottoPelle Method through their own practices. Patients locate certified providers via an online directory, while consumer demand is generated through content marketing, podcasts, and earned media. In parallel, Tutera Medical — a wholly owned subsidiary — operates four flagship clinics in Arizona providing direct BHRT services. The company has also extended into consumer products through three sub-brands: Caitera (nutraceuticals and professional hair care at caitera.com), Tutti (skin care at tutti.skin), and Bolster Beauty by SottoPelle® (nutritional supplements). Application areas span menopause, andropause, transgender hormone therapy, and neurodegenerative and traumatic brain injury indications, with prominent athlete testimonials (Jim McMahon, Paul Krause) supporting its TBI positioning. Pricing is not publicly disclosed; provider training requires direct inquiry and patient pellet therapy pricing is set independently by each certified provider.
Sotto Pelle Therapy firmographics
Firmographics- Name
- Sotto Pelle Therapy
- Legal name
- SottoPelle®, Inc.
- Website
- https://sottopelletherapy.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- SottoPelle Therapy is a Scottsdale-based, privately held BHRT company that trains and certifies a global network of 1,200+ medical providers in its proprietary subcutaneous pellet therapy, supported by the Dosaggio™ dosing platform, while operating flagship clinics and consumer wellness brands.
- Ownership category
- akta.pro rank
Sotto Pelle Therapy industry classification
Industry- Product category
- Bioidentical Hormone Replacement Therapy
- NAICS
- Offices of Other Health Practitioners (6213)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO)
- akta.pro secondary industries
- High-Potency API (HPAPI) Development & Manufacturing (HLAGAHAC), Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP) (HLAGAGAG), Drug Product Fill-Finish & Aseptic Manufacturing Services (HLAAAKAB)
Keywords
Where Sotto Pelle Therapy is headquartered
LocationHeadquarters
- HQ city
- Scottsdale
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Sotto Pelle Therapy business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain
Revenue model
- Provider Training & Certification: SottoPelle trains and certifies medical providers (physicians, PAs, nurse practitioners) in the SottoPelle pellet therapy method. Providers pay for training courses and certification to join the SottoPelle network. The company states it has over 1200 certified providers worldwide and 3000+ trained providers in the US.
- Tutera Medical — Patient Treatment: Tutera Medical, led by CEO CarolAnn Tutera, operates four flagship medical offices in Arizona providing direct patient BHRT pellet treatments — representing the company's own clinical delivery of hormone therapy services.
- Caitera — Nutraceuticals & Hair Care: Doctor-formulated nutraceuticals and professional hair care products sold through the Caitera online store (caitera.com). Products include hair repair formulas, ADK supplements, DIM supplement, boron supplements, and wellness products.
- Tutti — Skin Care: Skin care product line sold through tutti.skin, the company's own e-commerce storefront.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Provider Training & Certification |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
Sotto Pelle Therapy product offering
Product offeringCore offering
SottoPelle Therapy specializes in bioidentical hormone replacement therapy (BHRT) delivered via subcutaneous pellet implants that release plant-based hormones steadily over 4–6 months. The company trains and certifies medical providers (physicians, OB/GYNs, PAs, nurse practitioners) in the proprietary SottoPelle Method and licenses them access to the multi-patented Dosaggio™ individualized dosing platform. It also operates Tutera Medical flagship clinics in Arizona for direct patient treatment and sells affiliated nutraceutical (Caitera), skin care (Tutti), and supplement (Bolster Beauty by SottoPelle) consumer brands via e-commerce.
Product overview
SottoPelle® is a healthcare company specializing in bioidentical hormone replacement therapy (BHRT) using a proprietary pellet delivery system. The core offering is the SottoPelle® Method, which delivers customized hormone pellets subcutaneously every 4-6 months. The company operates alongside its companion technology Dosaggio™, a multi-patented dosing calculator that enables providers to calculate precise hormone dosages for individual patients. The product portfolio extends to consumer wellness brands including Caitera (nutraceuticals and professional hair care) and Bolster Beauty by SottoPelle® (nutritional supplements). SottoPelle® also operates a training and certification division for healthcare providers, teaching the SottoPelle® Method worldwide.
Differentiator
Problem solved
Functional benefit
Brands
- Caitera: Doctor-formulated nutraceuticals and professional hair care products designed to work in synergy for superior effectiveness and enhanced quality of life.
- Bolster Beauty by SottoPelle®
- Dosaggio™
Products and services
- SottoPelle® Method (Bioidentical Hormone Pellet Therapy) Proprietary bioidentical hormone replacement therapy using subcutaneous pellet implants that deliver consistent, 24/7 time-released dosing of plant-based hormones over 4–6 months, customized to individual patient needs. Indicated for menopause, andropause, transgender HRT, and select neurodegenerative/TBI cases. Delivered through certified SottoPelle providers or directly at Tutera Medical clinics.
- Dosaggio™ Dosing Platform Multi-patented web-based dosing calculator used by certified providers to calculate precise hormone dosages specific to each patient's body, supporting accurate individualization of the SottoPelle Method pellet protocol.
- SottoPelle® Provider Training & Certification Training and certification program that teaches physicians, OB/GYNs, PAs, and nurse practitioners the proprietary SottoPelle Method of bioidentical hormone pellet therapy, including use of the Dosaggio™ dosing platform. Includes separate course tracks for female, male, and transgender hormone replacement therapy.
- Tutera Medical — Direct Patient BHRT Care Direct bioidentical hormone pellet therapy patient treatment delivered through four flagship clinics in Arizona (Scottsdale/Phoenix area), operating as the company's owned clinical delivery channel for the SottoPelle Method.
- Caitera Nutraceuticals & Hair Care Doctor-formulated nutraceuticals and professional hair care products sold through the Caitera® e-commerce store, including Hair Repair Formula, Hair Savior Shampoo, Hair Protector Conditioner, ADK Essentials, DIMME (Diindolylmethane), and B-Your-Best (Boron) supplements designed for use alongside hormone therapy.
- Tutti Skin Care Skin care product line sold through the dedicated Tutti e-commerce storefront at tutti.skin, complementing the company's hormone therapy services.
- Bolster Beauty by SottoPelle® Nutritional Supplements Nutritional supplement line designed to support physical, mental, and spiritual well-being, launched by CarolAnn Tutera as a complementary offering to SottoPelle's hormone pellet therapy services.
Quantifiable outcome
- Over 250,000 patients treated worldwide over 30 years
- +4 more outcomes
Companies that use Sotto Pelle Therapy
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles2 records
Sotto Pelle Therapy technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Sotto Pelle Therapy partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Draft Nation PodcastminorSottoPelle is a proud sponsor of the Draft Nation Podcast, a popular show dedicated to sports, strategy, and drafting. The sponsorship aligns SottoPelle with a podcast audience focused on performance and peak athletic achievement, supporting the company's messaging around hormone health for sports performance, TBI recovery in athletes, and men's vitality.
Scale indicators6 records
Recent moves7 records
Expansion highlights5 records
Sotto Pelle Therapy competitors and assessment
Company assessmentEmerging players
- Equelle / Midi Health: Midi Health and similar emerging digital clinics deliver perimenopause and menopause care via telehealth, including non-pellet BHRT. They overlap with SottoPelle's core female menopause segment but are positioned around virtual, non-pellet delivery models.
Direct peers
- Defy Medical: Defy Medical is a hormone optimization clinic and telehealth provider specializing in testosterone replacement and hormone pellet therapy. It serves the same male andropause and female menopause patient segments that SottoPelle targets, including the men's vitality use case.
- BodyLogicMD: BodyLogicMD is a national network of physician-owned BHRT and wellness practices offering hormone pellet therapy, thyroid optimization, and integrative medicine. Like SottoPelle's Tutera Medical franchise, it sells a multi-provider clinic model aimed at the same menopausal and andropause patients.
- BioTE Medical: BioTE Medical is the largest direct competitor in bioidentical hormone replacement pellet therapy, operating a provider training and certification model nearly identical to SottoPelle with thousands of certified providers across the US. Both companies sell proprietary dosing protocols and compete for the same OB/GYN, family medicine, and PA prescriber audience.
- Evexias Health Restoration: Evexias Health Restoration trains and certifies providers in bioidentical hormone replacement therapy and functional medicine, including pellet-based protocols. It competes head-to-head with SottoPelle for provider training enrollments and patient referrals in the US.
- Pellecome: Pellecome offers a competing BHRT pellet delivery system and provider training program targeting the same OB/GYN and family medicine prescribers. It is comparable to SottoPelle's pellet platform and Dosaggio dosing approach as a direct substitute.
Others
- Martins Compounding Pharmacy: Martins and other 503A/503B compounding pharmacies supply the actual hormone pellets that SottoPelle-trained providers insert. They are upstream enablers whose regulatory fate directly affects the SottoPelle Method's ability to deliver therapy.
Broad incumbents
- Allergan / AbbVie ( hormone therapy portfolio): AbbVie and other large pharma firms sell FDA-approved hormone replacement products (patches, oral, injectables) that compete with pellet therapy for the same menopause/andropause indications. As broad incumbents they are not in the pellet niche but compete for the same patient population and prescriber mindshare.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Sotto Pelle Therapy social profiles
Digital presenceSotto Pelle Therapy financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sotto Pelle Therapy leadership team
Management profileNumber of profiles
Profiles5 records
Sotto Pelle Therapy subsidiaries and ownership
Company hierarchySubsidiaries3 records
Sotto Pelle Therapy funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sotto Pelle Therapy M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sotto Pelle Therapy
What does Sotto Pelle Therapy do?
SottoPelle Therapy specializes in bioidentical hormone replacement therapy (BHRT) delivered via subcutaneous pellet implants that release plant-based hormones steadily over 4–6 months. The company trains and certifies medical providers (physicians, OB/GYNs, PAs, nurse practitioners) in the proprietary SottoPelle Method and licenses them access to the multi-patented Dosaggio™ individualized dosing platform. It also operates Tutera Medical flagship clinics in Arizona for direct patient treatment and sells affiliated nutraceutical (Caitera), skin care (Tutti), and supplement (Bolster Beauty by SottoPelle) consumer brands via e-commerce.
Is Sotto Pelle Therapy a public or private company?
Sotto Pelle Therapy is a private company. It is classified as family owned and is currently operating.
When was Sotto Pelle Therapy founded?
Sotto Pelle Therapy was founded in 2004. It employs 51 to 100 people.
Where is Sotto Pelle Therapy based?
Sotto Pelle Therapy is headquartered in Scottsdale, United States, in the North America region.
How does Sotto Pelle Therapy make money?
Four revenue lines are on record. Provider Training & Certification is the primary driver. The others are tutera Medical — Patient Treatment, caitera — Nutraceuticals & Hair Care and tutti — Skin Care.
Who are Sotto Pelle Therapy's main competitors?
Equelle / Midi Health is listed as an emerging player. Direct peers are Defy Medical, BodyLogicMD, BioTE Medical, Evexias Health Restoration and Pellecome. Martins Compounding Pharmacy is listed as an others. Allergan / AbbVie ( hormone therapy portfolio) is listed as a broad incumbent.
Does Sotto Pelle Therapy have an API?
No public API is recorded for Sotto Pelle Therapy.
What industry is Sotto Pelle Therapy in?
Sotto Pelle Therapy's product category is Bioidentical Hormone Replacement Therapy. Its primary akta.pro industry code is HLAIACAO, Specialty Injectable & Infusion Therapies (Cross-therapeutic), with a secondary code of HLAGAHAC, High-Potency API (HPAPI) Development & Manufacturing. Its NAICS code is 6213 and its SIC code is 8011.